Publicaciones científicas

Comorbidity associated with obesity in a large population: The APNA study

Martin-Rodriguez E(1), Guillen-Grima F(2), Martí A(3), Brugos-Larumbe A(4).
(1) Departament of Health Science, Public University of Navarra, Pamplona, Spain; Servicio Navarro de Salud, Spain.
(2) Departament of Health Science, Public University of Navarra, Pamplona, Spain; Departament of Preventive Medicine, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain; IdiSNA (Navarra Institute for Health Research), Spain.
(3) IdiSNA (Navarra Institute for Health Research), Spain; Departament of Nutrition, Food Science and Physiology, University of Navarra, Pamplona, Spain; Biomedical Research Centre in Physiopathology of Obesity and Nutrition (CIBERobn), Physiopathology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain.
(4) Departament of Health Science, Public University of Navarra, Pamplona, Spain; Servicio Navarro de Salud, Spain; IdiSNA (Navarra Institute for Health Research), Spain.

Revista: Obesity Research & Clinical Practice

Fecha: 12/05/2015

Medicina Preventiva

BACKGROUND:
Overweight and obesity are major causes of comorbidities which can lead to further morbidity and mortality. The main objective of the present study was to estimate the comorbidity associated with obesity in 40,010 patients attending Primary Health Care Centres in Navarra.

METHODS:
It is a descriptive cross-sectional study. The association of overweight and obesity in different diseases was studied. Odds ratios (OR) adjusted for age and sex were calculated by unconditional logistic regression, using as reference patients with body mass index (BMI) lower than 25kg/m2.

RESULTS:
Increasing BMI is associated with glucose intolerance (OR: 1.07; 95% CI: 1.06-1.08), dyslipidemia (OR: 1.04; 95% CI: 1.03-1.04), hypertension (OR: 1.12; 95% CI: 1.12-1.13), type 2 diabetes (OR: 1.11; 95% CI: 1.10-1.11), kidney failure (OR: 1.04; 95% CI: 1.03-1.05), and osteoarthritis (OR: 1.06; 95% CI: 1.05-1.06). Moreover, all the degrees of obesity are associated with asthma (OR type I obesity: 1.33; OR type II obesity: 1.69; OR type III obesity: 1.75), heart failure (OR type I obesity: 1.68; OR type II obesity: 2.78; OR type III obesity: 4.35), and severe mental disorders (OR type I obesity: 2.02; OR type II obesity: 2.33; OR type III obesity: 2.50). Type II and morbid obesity are associated with chronic obstructive pulmonary disease and depression.

CONCLUSION:
Our study showed a positive association of the overweight and obesity with glucose intolerance, dyslipidemia, type 2 diabetes, hypertension, osteoarthritis, and kidney failure. An interesting point is the association of higher levels of BMI with depression.

CITA DEL ARTÍCULO  Obes Res Clin Pract. 2015 May 12. pii: S1871-403X(15)00057-5. doi: 10.1016/j.orcp.2015.04.003. 

tal vezLE INTERESE

¿QUÉ TECNOLOGÍA UTILIZAMOS?

La Clínica es el hospital privado con mayor dotación tecnológica de España, todo en un único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

NUESTROS
PROFESIONALES

Los profesionales de la Clínica realizan una labor continuada de investigación y formación, siempre en beneficio del paciente.

Imagen profesionales de la Clínica Universidad de Navarra

POR QUÉ VENIR
A LA CLÍNICA

Conozca por qué somos diferentes a otros centros sanitarios. Calidad, rapidez, comodidad y resultados.

Imagen del edificio de la Clínica Universidad de Navarra